Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-15 Chappell Todd Chief Operating Officer Grant or award +7,500 24,464
2026-06-16 Chappell Todd Chief Operating Officer Sale −3,168 $10.83 $34K 16,964
2026-02-02 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +38,000 38,000
2025-12-15 Chappell Todd Chief Operating Officer Grant or award +20,132 20,132
2025-02-03 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +34,500 34,500
2023-11-03 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +13,625 13,625
2023-11-03 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +4,968 4,968
2023-11-03 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +5,128 5,128
2023-11-03 Chappell Todd Chief Operating Officer Grant or award · Stock Option (Right to Buy) +62,651 62,651

Page 1 of 1 · 9 trades